Abstract
Background:
Probiotics decrease the risk of necrotizing enterocolitis (NEC). We sought to determine the impact of Bifidobacterium longum subsp. infantis (B. infantis) in the established rat model of NEC.
Methods:
Rat pups delivered 1 d prior to term gestation were assigned to one of three groups: dam fed (DF), formula fed (FF), or fed with formula supplemented with 5 × 106 CFU B. infantis per day (FF+Binf). Experimental pups were exposed to hypoxia and cold stress. Ileal tissue was examined for pathology and expression of inflammatory mediators, antimicrobial peptides, and goblet-cell products. Ceca were assessed for bacterial composition by analysis of the 16S rRNA sequence.
Results:
Administration of B. infantis significantly reduced the incidence of NEC, decreased expression of Il6, Cxcl1, Tnfa, Il23, and iNOS, and decreased expression of the antimicrobial peptides Reg3b and Reg3g. There was significant microbial heterogeneity both within groups and between experiments. The cecal microbiota was not significantly different between the FF and FF+Binf groups. Bifidobacteria were not detected in the cecum in significant numbers.
Conclusion:
In the rat model, the inflammation associated with NEC was attenuated by administration of probiotic B. infantis. Dysbiosis was highly variable, precluding determination of the precise role of the microbiota in experimental NEC.
Similar content being viewed by others
Main
Necrotizing enterocolitis (NEC) is a common and devastating disease that predominantly affects premature infants. Experimental and clinical research over four decades has revealed much about NEC risk factors (prematurity, enteral feeding, and exposure to antibiotics) and contributing mechanisms (dysbiosis, altered apoptosis, translocation of bacteria through an inadequate barrier, exuberant pro-inflammatory cascade, and in severe cases coagulopathy, gut necrosis, and shock) (1,2,3). The most promising preventative approaches to date include provision of human milk and probiotics (4,5). The observations that many Enterobacteriaceae outcompete commensal organisms in the inflamed intestine by utilizing an alternative respiratory pathway (6), together with the recent descriptions of a bloom of Enterobacteriaceae associated with NEC (7) shed new light on a possible central role of the intestinal microbiota in this disease.
The neonatal rat model of NEC is an invaluable experimental tool for examining the pathogenesis of NEC and potential mechanisms of protection (8,9,10). The strength of this model is its inclusion of stressors and enteral feeding, both of which are factors associated with human NEC. In the rat model, the stressors include separation from the dam, tube feeding, hypoxia, hypothermia, and enteral nourishment with bovine-based rat milk substitute (11).
Previous studies with this model have demonstrated a protective effect of probiotic Bifidobacterium bifidum with decreased NEC, decreased apoptosis, and decreased inflammation (8,9,10). Mouse and piglet studies have demonstrated alterations of the intestinal microbiota in NEC (12,13); however, changes in the microbiota in the rat NEC model and the impact of probiotic bifidobacteria on this microbial community have not yet been investigated.
In this study, we chose to analyze a different probiotic strain, Bifidobacterium longum subsp. infantis (B. infantis), for the following reasons. First, this bacterial strain has evolved the genetic capacity to thrive in the breast-fed human infant (14). Encoded in its genome are several unique glycosidases capable of deconstructing human milk oligosaccharides that are not found in other bifidobacteria (15). Second, B. infantis grown in culture media containing human milk oligosaccharides shows increased epithelial cell adhesion compared with B. bifidum grown under identical conditions (16). Third, this strain was shown in a phase 1 trial to be a superior colonizer of the premature infant intestinal tract (17). Finally, in a population of breast-fed infants in Bangladesh, relative percentages of B. infantis were associated with improved growth and increased responsiveness to several routine vaccines (18). We hypothesized that B. infantis in the rat NEC model would decrease the severity of NEC, decrease markers of inflammation, alter intestinal antimicrobial peptides and mediators of mucus production, and alter the cecal microbiota by decreasing Enterobacteriaceae and increasing bifidobacteria.
Results
B. infantis Decreased the Incidence and Severity of NEC
Figure 1 presents the incidence of NEC, the ileal histology scores, and the villus length and width for all the animals exposed to asphyxia and cold stress (n=50). Consistent with previous investigations (8,9,10), the formula-fed (FF) group showed an increased incidence of NEC ( Figure 1a ), an increased histologic score for NEC ( Figure 1b ), a decreased mean villous length ( Figure 1c ), and a decreased mean villous width compared with dam-fed (DF) controls ( Figure 1d ). The administration of B. infantis was protective in the FF group as manifested by a decreased incidence of NEC, a decreased histologic score, and an increased mean villous length ( Figure 1a – c ).
B. infantis Decreased Inflammation
Figure 2a summarizes the relative mRNA expression encoding pro-inflammatory (Il6, Cxcl1, Tnfa, and Il23) and anti-inflammatory (Il10) cytokines important in the pathogenesis of NEC. The significantly increased mRNA of pro-inflammatory cytokines in the FF group was attenuated by administration of B. infantis. Il10 mRNA was suppressed by formula feeding, but was not significantly rescued by B. infantis.
Inducible nitric oxide synthase (iNOS or Nos2) is a marker of inflammation and Toll-like receptors (TLR) 2 and 4 are important sensors of microbial patterns that trigger inflammatory responses. Figure 2b summarizes iNOS, TLR4, and TLR2 expression at the protein and mRNA levels in the three treatment groups. Both Nos2 and Tlr2 were significantly increased in the FF group and attenuated by B. infantis at the mRNA level, but these changes were not significant at the protein level in a small subset of specimens. Tlr4 was unexpectedly decreased in the FF and FF+Binf group and not consistent with previous observations (11,19). We currently have no explanation for this observation.
B. infantis Attenuated Increased Expression of Antimicrobial Peptides
Reg3B and Reg3G, antimicrobial proteins of the Reg family of C-type lectins, are produced by both Paneth cells and enterocytes, and are secreted into the intestinal lumen in even very young rat pups (20,21). Reg3b and Reg3g were increased in the FF group and attenuated in the FF+Binf group ( Figure 2c ). These changes were similar to previous observations in this model with administration of B. bifidum (10).
B. infantis Altered Mucus Production
TFF3 is a peptide secreted by goblet cells and serves to stabilize the mucus layer and trigger regeneration of the injured epithelial layer, while MUC2 is the predominant glycoprotein component of the mucus layer. A decrease in TFF3-positive cells in the FF group was rescued by B. infantis ( Figure 2d ). MUC2 was increased in both the FF and FF+Binf groups. These changes occurred in the opposite direction from those reported with administration of B. bifidum (8), suggesting the possibility that bifidobacterial strains have differing impact on intestinal mucus production.
Changes in the Cecal Microbiota Were Inconsistent
The microbiota of the cecal lumen was determined in animals identically challenged in two different experiments performed 4 mo apart. At the phylum level, there was significant heterogeneity in the cecal microbiota within a given animal group and between experiments in spite of identical diet and experimental conditions. In all animals the dominant phyla were Firmicutes and Proteobacteria. In experiment A ( Figure 3a ), the cecal microbiota was dominated by Firmicutes in the DF group and by Proteobacteria in the FF group. This pattern was not seen in experiment B ( Figure 3b ). Although the number is too small for statistical analysis, there were no obvious differences in the microbiota when comparing animals exposed or not exposed to asphyxia and cold stress within each group (in experiment A, Figure 3a ; all animals in experiment B were exposed to asphyxia and cold stress).
Linear discriminant analysis (LDA) is a method for demonstrating differences in complex datasets. Bars represent taxa that are dominant in a given group; the length of each bar represents the level of significance with LDA scores > 2 considered statistically significant. In experiment A ( Figure 3c ), there were significantly higher numbers of seven taxa in the FF group (green bars), ten taxa in the DF group (red bars), and nine taxa in the FF+Binf group (blue bars). In experiment B ( Figure 3d ), the dominant taxa in each group were dramatically different from those observed in experiment A.
Cladograms and principal coordinate analyses are complementary methods for illustrating differences between microbial communities. In the cladogram (Supplementary Figure S1 online), the innermost circle represents phylum, the next circle outward representing class, etc. Taxa that were more prominent in pups from a given group are color coded; the remaining taxa were present in at least one group and not significantly different between groups (tallow nodes in the cladograms). In experiment A, the FF group was dominated by γ-Proteobacteria, the DF group was dominated by Firmicutes (mostly Lactobacillales), and the FF+Binf group had features of both. The microbial composition was markedly different in experiment B with all groups showing a mix of γ-Proteobacteria and Firmicutes plus some Bacteroidetes (DF group) and Actinobacteria (FF+Binf group). Principal coordinate analyses based on Unifrac distances demonstrate the pronounced differences between groups in experiment A ( Figure 3e ) that is less apparent in experiment B ( Figure 3f ).
Figure 4 presents relative abundances of three taxa of interest for each group (panel a from experiment A and panel b from experiment B). The differences in the DF groups between the two experiments are dramatic. While the differences between the FF and the FF+Binf groups did not reach statistical significance, in both experiments there were consistent trends: a relative increase in Lactobacillaceae and decreases in Enterobactericeae and Enterococcaceae in the FF+Binf group. Bifidobacteria were not present in the ceca in significant numbers in any group. Rarefaction curves demonstrate a trend towards differing species richness and diversity between groups in experiment A, which is not seen in experiment B (Supplementary Figure S2 online).
Linear regression of percentage of two dominant taxa (Enterobacteriaceae and Lactobacillaceae) with IL6, IL8, IL23, and iNOS expression for all 50 pups exposed to stress in both experiments demonstrated a weak correlation between iNOS and Enterobacteriaceae ( Figure 5a ). This association was stronger when analyzing just the stressed pups in experiment A ( Figure 5b ), but nonsignificant when analyzing the pups in experiment B (data not shown). A negative association between Lactobacillaceae and iNOS was observed in experiment A ( Figure 5c ) but not experiment B. To assess the impact of one outlier with very high iNOS expression, the analyses were repeated without including that pup ( Figure 5 , right panels).
Discussion
Probiotics decrease the risk of NEC in premature infants, but the mechanisms of protection are unclear. Previous studies of probiotics in animal models of NEC show efficacy and support several possible mechanisms, including decreased apoptosis (9,22), improved intestinal integrity (8), and altered expression of antimicrobial peptides (10). In vitro studies have demonstrated that factors secreted by B. infantis suppress expression of innate immune response genes (including Tlr2, Tlr4, Il6, and Il8), resulting in decreased inflammation in immature, but not mature intestinal cells and tissues (23). A recent comparison of three Bifidobacterium and two Lactobacillus strains in the rat model of NEC found differences in protective ability among strains and no clear benefit of combinations over single strains (24). In vitro, B. infantis was superior to L. acidophilus in reducing innate immune gene expression and inflammation (23).
Our findings here support the hypothesis that B. infantis decreases the incidence and severity of NEC, and attenuates the hyper-inflammatory immune response of the immature intestinal mucosa as evidenced by decreases in expression of pro-inflammatory cytokines and Nos2 (iNOS). The results of experiment A are consistent with the hypothesis that a pro-inflammatory milieu stimulates an overgrowth of several species of Enterobacteriaceae (6,25); however, this association was not seen in experiment B.
Circumstantial evidence strongly supports a role for dysbiosis in the pathogenesis of NEC. In the mouse, experimental NEC is associated with increased Enterobacteriaceae (particularly Citrobacter and Klebsiella species) and decreased microbial diversity (12), whereas in the piglet experimental NEC is associated with increased surface-associated Clostridia species (13). Surveys of the fecal microbiota in premature infants demonstrate that dysbiosis due to increased Enterobacteriaceae is associated with NEC (7,26). Early dysbiosis may predispose premature infants to subsequent development of NEC (27), and increased administration of antibiotics (28,29) and acid-blocking agents (30,31) are both associated with dysbiosis and with increased susceptibility to NEC. In experiment A, we found marked dysbiosis in the FF group with high levels of Enterobacteriaceae that was partially attenuated by B. infantis; however, this pattern was not seen in experiment B. While the numbers are too small for conclusions, the data suggest that hypoxia and cold stress might not significantly alter the cecal microbiota, and that in the FF group the observed changes reflect either an effect of formula feeding or the stress of being housed without a surrogate dam (or both).
Despite the protective effects of probiotic clearly evident in the current study, the numbers of bifidobacteria in the cecum were very small in both experiments, suggesting that either the protective effects of this strain occurred “upstream” from the cecum, or perhaps more likely the beneficial effects require only minimal colonization. It would have been ideal to examine the microbiota of the distal ileum; however, the limited ileal tissue was used to assess NEC pathology, mRNA, and protein. Future studies in this model comparing the microbiota of the distal ileum and the cecum at days 1–4 of life would be valuable in further investigating the development of dysbiosis.
The marked differences between the two identical experiments underscore a variability in the cecal microbial community that remains unexplained, but worthy of comment. The two experiments were performed 4 mo apart with animals from the same facility receiving identical diets and interventions. We have previously noted that transportation of mice can cause a transient but significant alteration in the intestinal microbiota (loss of Lactobacilli) (32). We speculate that some unknown stressor increased the Enterobacteriaceae and decreased the Lactobacillaceae in the DF group in experiment B; it is striking that in spite of high numbers of Enterobacteriaceae, none of the pups in the DF group in experiment B developed NEC. Although we have previously demonstrated that infection with Helicobacter hepaticus (often asymptomatic in laboratory animals) worsens the severity of NEC in this model (11), we did not find significant numbers of H. hepaticus (phylum Proteobacteria, class ɛ-Proteobacteria) in either experiment A or B.
In spite of the marked differences in the microbiota between experiments A and B, the incidence and severity of NEC and the changes in markers of inflammation, antimicrobial peptides, and mucus-related molecules were very similar between experiments. This observation may suggest that changes in the microbiota in this model of experimental NEC are secondary to inflammation rather than directly causative of disease. An alternative explanation is that in the presence of significant stress, even subtle changes in the microbiota increase the risk of NEC.
Two key questions will require further investigation. First, is dysbiosis a cause or consequence of NEC disease? One scenario is that formula feeding and environmental stress trigger tissue inflammation, which in turn leads to NEC and to alterations in the gut microbiota, but the dysbiosis is of minimal consequence. Another scenario is that perturbation in host–microbe homeostasis induced by formula feeding and environmental stress causes a dysbiosis, and that the altered composition of the microbiota causes inflammation and mucosal disease. The data from this study tend to favor the first scenario, but are not definitive. Furthermore, we do not view the two scenarios as mutually exclusive, i.e., dysbiosis and inflammation may escalate each other, ultimately resulting in NEC.
The second key question is how does B. infantis prevent NEC? B. infantis might exert its effects primarily on host mucosa by suppressing detrimental inflammation (23) or by altering mucus or antimicrobial peptide expression. On the other hand, B. infantis might mediate its protective properties by attenuating dysbiosis via microbe–microbe interactions. Answers to these questions will likely help in developing more effective preventative and therapeutic interventions for NEC.
Methods
This protocol was approved by the Animal Care and Use Committee of the University of Arizona. Neonatal Sprague–Dawley rats (Harlan Laboratories, Madison, WI) were collected by Caesarean section 1 d before scheduled birth and their first feeding started 2 h after delivery. Rat pups were hand-fed five times daily with a total volume of 850 µl of rat milk substitute formula (11) (FF, n = 20), the identical formula plus 5 × 106 CFU per day of Bifidobacterium longum subsp. infantis ATCC 15697 (FF+Binf, n = 19), or dam-fed by surrogate mothers (DF, n = 20). The dose is the same as in previous experiments with a different bifidobacterium (8) and is comparable in CFU/g body weight to doses given to premature infants. Fifty animals (FF 17, FF+Binf 17, and DF 16) were exposed to asphyxia (breathing 100% nitrogen gas for 60 s) and cold stress (4 °C for 10 min) twice daily; the remaining nine animals were not exposed to asphyxia or cold stress. After 96 h, all of the surviving animals were killed by decapitation. Animals that developed signs of distress or imminent death before 96 h were killed and included in the study (n=1, DF).
NEC Evaluation
After euthanasia, a 2-cm piece of distal ileum was removed and fixed in 70% ethanol, paraffin embedded, sectioned at 4–6 µm, and stained with hematoxylin and eosin (H&E) for histological evaluation of NEC. Pathological changes in intestinal architecture were evaluated using our previously published NEC scoring system (8,33). Histological changes in the ileum were scored by a blinded evaluator and graded as follows: 0 (normal)—no damage; 1 (mild)—slight submucosal and/or lamina propria separation; 2 (moderate)—moderate separation of submucosa and/or lamina propria, and/or edema in submucosal and muscular layers; 3 (severe)—severe separation of submucosa and/or lamina propria, and/or severe edema in submucosa and muscular layers, regional villous sloughing; 4 (necrosis)—loss of villi and necrosis. Intermediate scores of 0.5, 1.5, 2.5, and 3.5 were also utilized to more accurately assess levels of ileal damage when necessary (34). Experimental NEC was defined as a histologic score of 2 or greater (8,35).
Morphometric Measurements in the Ileum
A 2-cm section of distal ileum stained with H&E was used for morphometric measurements as previously described (34). Briefly, 20 villi were measured in each histological sample and 8–10 animals were evaluated per experimental group. Sections from animals with a NEC score of 3 and higher were not included in analyses because of the lack of intact tissue to evaluate. Villi were measured from the tip to the crypt base using an image analysis system (Image-Pro Plus; Media Cybernetics, Silver Spring, MD) in a blind manner to prevent observer bias.
RNA Preparation and Real-Time Polymerase Chain Reaction
Total RNA was isolated from ileal tissue using the RNeasy Mini Kit (Qiagen, Santa Clarita, CA). RNA concentration was quantified by ultraviolet spectrophotometry at 260 nm using a NanoDrop (Thermo Fisher Scientific, Wilmington, DE). cDNA synthesis and real-time PCR were performed as previously described (10). The PCR primers for Reg3b (NM053289, also referred to as Pap1) and Reg3g (NM 173097, also referred to as Pap3) have been previously reported (10). TaqMan primers and probes were used for the detection of Nos2, Cxcl1, Il6, Il23, Muc2, Tff3, Tlr2, and Tlr4. Reporter dye emission was detected by an automated sequence detector combined with ABI Prism 7700 Sequence Detection System software (Applied Biosystems, Foster City, CA). Real-time PCR quantification was then performed using TaqMan 18S controls.
Western Blot Analysis
Ileal tissue was examined for protein expression of TLR2 and TLR4 as well as iNOS as previously described (9). The following antibodies (all from Santa Cruz Biotechnology, Dallas, TX) were used: goat anti-TLR-4 polyclonal antibody (1:500, sc-3002), goat anti-TLR-2 polyclonal antibody (1:500, sc-16237), or mouse anti-NOS2 monoclonal antibody (1:500, sc-7271).
Microbiota Analysis
To ensure accurate detection of bifidobacteria, preliminary analyses were performed on unrelated specimens with and without the additional steps of bead beating and addition of lysis buffer (Supplementary Figure S3 online). Consistent with a previous report, these results underline the necessity of both steps to ensure detection of bifidobacteria (36). For all microbiota studies, intact ceca were placed in 5 ml of RNAlater solution (Qiagen) (37), kept at 4 °C overnight, and then stored at −80 °C until processing. Ceca samples were thawed and DNA was extracted using the QIAamp DNA Stool Mini Kit (Qiagen) with the additional enzymatic lysis and homogenization by bead beating (36).
Illumina Sequencing
Amplification and sequencing were performed as described previously (38). Briefly, the V4 domain of bacterial 16S rRNA genes was amplified using primers F515 (5′-NNNNNNNN GTGTGCCAGCMGCCGCGGTAA-3′) and R806 (5′-GGACTACHVGGGTWTCTAAT-3′) (39), with the forward primer modified to contain a unique 8 nt barcode (italicized poly-N section of the primer above) and a 2 nt linker sequence (bold, underlined portion) at the 5′ terminus. PCR reactions contained 5–100 ng DNA template, 1X GoTaq Green Master Mix (Promega, Madison, WI), 1 mmol/l MgCl2, and 2 pmol of each primer. Reaction conditions consisted of an initial 94 °C for 3 min followed by 35 cycles of 94 °C for 45 s, 50 °C for 60 s, and 72 °C for 90 s, and a final extension of 72 °C for 10 min. PCR amplicons were pooled at roughly equal amplification intensity ratios, purified using the Qiaquick PCR purification kit (Qiagen), and submitted to the UC Davis Genome Center DNA Technologies Core for Illumina paired-end library preparation, cluster generation, and 250 bp paired-end sequencing on an Illumina MiSeq instrument.
Sequencing Analysis
The QIIME software package (University of Colorado, Boulder, CO, version 1.7.0) was used to analyze data from the sequencing run (39,40). Sequences were quality filtered and demultiplexed, and then operational taxonomic units (OTUs) were assigned using UCLUST (drive5.com, Tiburon, CA) (41), based on 97% pairwise identity as previously described (38). OTUs went through a secondary filtration by 0.005% to remove low-abundance OTUs (38). Taxonomic classification of the filtered OTUs was based on the Ribosomal Database Project classifier (Michigan State University, East Lansing, MI) (42) against a representative subset of the Greengenes 16S rRNA database (Second Genome, South San Francisco, CA, gg_13_5 release) (43). OTU sequence alignment was carried out with PyNAST (University of Colorado) (38,44) and used to build a phylogenetic tree for β diversity analyses. β diversity was estimated by calculating abundance-weighted and unweighted UniFrac (45) distances. Samples were clustered based on between-sample distances.
The linear discriminate analysis (LDA) effect size (LEfSe) (46) module (Galaxy, Boston, MA) for biomarker discovery was used to determine taxonomically significant differences between the DF, FF, and FF+Binf groups. LEfSe uses a factorial Kruskal–Wallis sum-rank test (α = 0.05) to identify taxa with significant differential abundances between categories (using one-against-all comparisons), followed by a Wilcoxon Mann–Whitney test to assess subclass variation, and LDA to determine the effect size of each differentially abundant taxon.
Statistical Analysis
DF, FF, and FF+Binf groups were compared using ANOVA followed by Fisher PLSD and by the Student’s t-test at the 95% CI. Analysis of NEC score between groups was accomplished using the Kruskal–Wallis test for nonparametric values followed by pairwise comparison using the Mann–Whitney test. The Pearson’s chi-squared (χ2) test was used to analyze differences in incidence of NEC between groups. All statistical analyses were conducted using the statistical program StatPlus:mac LE for Macintosh computers (AnalystSoft, Alexandria, VA). All numerical data are expressed as mean ± SE.
Statement of Financial Support
UC Davis, Davis, CA: National Institutes of Health (NIH) HD059127 (M.A.U., C.L.B., D.A.M.), NIH AI32738 (C.L.B.), NIH AT007079 (D.A.M.), The Development and Promotion of Science and Technology Talents Project, Thailand (A. Kananurak). U Arizona, Tucson, AZ: NIH HD039657, Mead Johnson, and Meiji Dairies Co (B.D.).
Disclosure
There are no conflicts of interest.
References
Hackam DJ, Good M, Sodhi CP . Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch. Semin Pediatr Surg 2013;22:76–82.
Carlisle EM, Morowitz MJ . The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr 2013;25:382–7.
Neu J, Walker WA . Necrotizing enterocolitis. N Engl J Med 2011;364:255–64.
Underwood MA . Human milk for the premature infant. Pediatr Clin North Am 2013;60:189–207.
Deshpande G, Rao S, Patole S, Bulsara M . Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921–30.
Winter SE, Winter MG, Xavier MN, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013;339:708–11.
Mai V, Young CM, Ukhanova M, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011;6:e20647.
Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009;297:G940–9.
Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, Dvorak B . Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010;299:G1118–27.
Underwood MA, Kananurak A, Coursodon CF, et al. Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res 2012;71:546–51.
Dvorak K, Coursodon-Boyiddle CF, Snarrenberg CL, Kananurak A, Underwood MA, Dvorak B . Helicobacter hepaticus increases intestinal injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2013;305:G585–92.
Carlisle EM, Poroyko V, Caplan MS, Alverdy JA, Liu D . Gram negative bacteria are associated with the early stages of necrotizing enterocolitis. PLoS One 2011;6:e18084.
Azcarate-Peril MA, Foster DM, Cadenas MB, et al. Acute necrotizing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria. Gut Microbes 2011;2:234–43.
Sela DA, Mills DA . Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol 2010;18:298–307.
Kim JH, An HJ, Garrido D, German JB, Lebrilla CB, Mills DA . Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans. PLoS One 2013;8:e57535.
Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA . Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr 2012;55:321–7.
Underwood MA, Kalanetra KM, Bokulich NA, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 2013;163:1585–1591.e9.
Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, Raqib R, et al. Stool microbiota and vaccine responses of infants. Pediatrics 2014;e-pub ahead of print 7 July 2014.
Chan KY, Leung KT, Tam YH, et al. Genome-wide expression profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Ann Surg 2013; e-pub ahead of print 23 December 2013.
Iovanna JL, Dagorn JC . The multifunctional family of secreted proteins containing a C-type lectin-like domain linked to a short N-terminal peptide. Biochim Biophys Acta 2005;1723:8–18.
Mukherjee S, Vaishnava S, Hooper LV . Multi-layered regulation of intestinal antimicrobial defense. Cell Mol Life Sci 2008;65:3019–27.
Lin PW, Nasr TR, Berardinelli AJ, Kumar A, Neish AS . The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr Res 2008;64:511–6.
Ganguli K, Meng D, Rautava S, Lu L, Walker WA, Nanthakumar N . Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 2013;304:G132–41.
Wu SF, Chiu HY, Chen AC, Lin HY, Lin HC, Caplan M . Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model. J Pediatr Gastroenterol Nutr 2013;57:23–8.
Winter SE, Thiennimitr P, Winter MG, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010;467:426–9.
Wang Q, Dong J, Zhu Y . Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012;47:241–8.
Normann E, Fahlén A, Engstrand L, Lilja HE . Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr 2013;102:129–36.
Cotten CM, Taylor S, Stoll B, et al.; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58–66.
Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009;3:944–54.
Terrin G, Passariello A, De Curtis M, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 2012;129:e40–5.
Gupta RW, Tran L, Norori J, et al. Histamine-2 receptor blockers alter the fecal microbiota in premature infants. J Pediatr Gastroenterol Nutr 2013;56:397–400.
Ma BW, Bokulich NA, Castillo PA, et al. Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLoS One 2012;7:e47416.
Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282:G156–64.
Coursodon-Boyiddle CF, Snarrenberg CL, Adkins-Rieck CK, et al. Pomegranate seed oil reduces intestinal damage in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2012;303:G744–51.
Ran-Ressler RR, Khailova L, Arganbright KM, et al. Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model. PLoS One 2011;6:e29032.
Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J . Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 2010;5:e15046.
Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11:76–83.
Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods 2013;10:57–9.
Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA 2011;108:Suppl 1:4516–22.
Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335–6.
Edgar RC . Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460–1.
Wang Q, Garrity GM, Tiedje JM, Cole JR . Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261–7.
DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069–72.
Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R . PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010;26:266–7.
Lozupone C, Knight R . UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005;71:8228–35.
Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
Acknowledgements
B.D., C.L.B., D.A.M., and M.A.U. conceived and designed the research; A.K., A.K., C.W.G., J.A., and K.M.K. performed experiments and measurements; B.D., M.A.U., and K.M.K. analyzed the data; B.D., C.L.B., D.A.M., M.A.U., and K.M.K. interpreted the results of experiments; M.A.U. drafted the manuscript; B.D., C.L.B., D.A.M., and M.A.U. edited and revised the manuscript; all coauthors approved the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Figure S1
(TIFF 2227 kb)
Supplementary Figure S2
(TIFF 974 kb)
Supplementary Figure S3
(TIFF 90 kb)
Rights and permissions
About this article
Cite this article
Underwood, M., Arriola, J., Gerber, C. et al. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 76, 326–333 (2014). https://doi.org/10.1038/pr.2014.102
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/pr.2014.102
This article is cited by
-
Bifidobacterium infantis as a probiotic in preterm infants: a systematic review and meta-analysis
Pediatric Research (2023)
-
Bifidobacterium bifidum and Bacteroides fragilis Induced Differential Immune Regulation of Enteric Glial Cells Subjected to Exogenous Inflammatory Stimulation
Inflammation (2022)
-
Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age
Microbial Cell Factories (2021)
-
Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells
BMC Microbiology (2020)
-
Hope on the horizon: promising novel therapies for necrotizing enterocolitis
Pediatric Research (2020)